Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - CRISPR Therapeutics (NASDAQ: CRSP)
Follow
NASDAQ:CRSP
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
03/21/2025
Sell
$41.23
10,031
$414K
195,085
NASDAQ
CRSP
CRISPR Therapeutics
Bruno Julianne
/
officer: Chief Operating Officer
03/21/2025
Sell
$41.23
1,714
$71K
10,544
NASDAQ
CRSP
CRISPR Therapeutics
Prasad Raju
/
officer: Chief Financial Officer
03/21/2025
Sell
$41.23
2,197
$91K
16,767
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
03/21/2025
Sell
$41.23
3,185
$131K
81,729
NASDAQ
CRSP
CRISPR Therapeutics
Patel Naimish
/
officer: Chief Medical Officer
03/14/2025
Buy
$42.12
46,667
$1.966M
46,667
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
03/14/2025
Buy
$42.12
110,000
$4.633M
110,000
NASDAQ
CRSP
CRISPR Therapeutics
Prasad Raju
/
officer: Chief Financial Officer
03/14/2025
Buy
$42.12
36,666
$1.544M
36,666
NASDAQ
CRSP
CRISPR Therapeutics
Prasad Raju
/
officer: Chief Financial Officer
03/17/2025
Sell
$41.80
3,762
$157K
12,714
NASDAQ
CRSP
CRISPR Therapeutics
Bruno Julianne
/
officer: Chief Operating Officer
03/14/2025
Buy
$42.12
36,666
$1.544M
36,666
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
03/14/2025
Buy
$42.12
36,666
$1.544M
36,666
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
03/12/2025
Sell
$43.32
4,462
$193K
185,428
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
03/11/2025
Sell
$42.42
9,973
$423K
180,890
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
03/12/2025
Sell
$43.32
1,116
$48K
78,664
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
03/11/2025
Sell
$42.42
2,850
$121K
77,530
NASDAQ
CRSP
CRISPR Therapeutics
Bruno Julianne
/
officer: Chief Operating Officer
03/12/2025
Sell
$43.32
190
$8K
8,508
NASDAQ
CRSP
CRISPR Therapeutics
Bruno Julianne
/
officer: Chief Operating Officer
03/11/2025
Sell
$42.42
1,198
$51K
8,263
NASDAQ
CRSP
CRISPR Therapeutics
Greene John
/
director
02/26/2025
Buy
$44.85
7,000
$314K
7,000
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
02/19/2025
Sell
$55.21
18,360
$1.014M
171,613
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
02/18/2025
Sell
$55.05
11,640
$641K
196,901
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
02/19/2025
Sell
$52.80
6,928
$366K
189,973
NASDAQ
CRSP
CRISPR Therapeutics
Bruno Julianne
/
officer: Chief Operating Officer
02/19/2025
Sell
$52.80
333
$18K
7,062
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
02/19/2025
Sell
$52.80
1,947
$103K
74,880
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
02/18/2025
Sell
$53.85
9,595
$517K
73,002
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.